Healthcare >> Analyst Interviews >> August 23, 2013

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs

Tenthoff, Ted
Ted Tenthoff is a Managing Director and Senior Research Analyst at Piper Jaffray & Co., focused on the drug discovery sector of the biotech industry. In April 2013, Mr. Tenthoff moderated a cardiovascular medicine panel at the International Adult Stem Cell Conference at the Vatican. He was ranked the number-two stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked number one stock picker for the life science tools and services sector in the 2006 StarMine Analyst Awards. Prior to joining Piper Jaffray & Co. in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Mr. Tenthoff received a bachelor's in international relations from the University of Pennsylvania. Profile
TWST: This is for our focus on biotech. The group has certainly done well over the last year, particularly versus the market. What's been the driving force in that strong